Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025

By Yahoo! Finance | 1 month ago

Avadel Pharmaceuticals plc will showcase 14 new abstracts at SLEEP 2025, highlighting advancements for their narcolepsy treatment, LUMRYZ. Results showed significant improvements in daytime sleepiness and other symptoms, emphasizing the benefits of once-at-bedtime dosing.

Did you find this insightful?